Navigation Links
Sunesis Reports Financial Results for the First Quarter 2009

e in events, conditions or circumstances on which any such statements are based.

    Investor Contact:                      Media Contact:
    Sunesis Pharmaceuticals, Inc.          Sunesis Pharmaceuticals, Inc.
    Eric Bjerkholt                         Dan Weinseimer
    650-266-3717                           650-266-3739

                        SUNESIS PHARMACEUTICALS, INC.

                                               March 31,   December 31,
                                                 2009          2008
                                              ----------   -----------
    ASSETS                                    (unaudited)    (Note 1)
    Current assets:
         Cash and cash equivalents             $4,280,363    $6,296,942
         Marketable securities                          -     4,321,844
         Prepaids and other current assets        763,074       934,429
                                               ----------   -----------
    Total current assets                        5,043,437    11,553,215
    Property and equipment, net                   501,751       612,241
    Assets held-for-sale                           50,427       470,547
    Deposits and other assets                      96,824       147,826
                                               ----------   -----------
    Total assets                               $5,692,439   $12,783,829
                                               ==========   ===========

    Current liabilities:
         Accounts payable and other accrued
          liabilities                          $1,994,735    $2,150,980
         Accrued clinical expense               1,794,154     1,865,773
         Accrued compensation                     845,649       537,215
         Accrued restructuring charges      
SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
2. Sunesis Pharmaceuticals Reports New Option Grants Under NASDAQ Marketplace Rule 4350
3. Sunesis Pharmaceuticals SNS-595 Shows Clinical Activity in Patients With Relapsed or Refractory Acute Leukemias; Data Presented in Oral Session at 49th Annual Meeting of the American Society of Hematology
4. Sunesis Pharmaceuticals to Present at Healthcare Investor Conferences in March
5. Sunesis Pharmaceuticals Presents Nonclinical Data on SNS-595 at the Annual Meeting of the American Association for Cancer Research
6. Sunesis Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
7. Sunesis Pharmaceuticals to Present at the Collins Stewart Fourth Annual Growth Conference
8. Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing
9. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
10. Haemacure Reports Third Quarter 2007 Results
11. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
Post Your Comments:
(Date:4/17/2014)... NY In a review published in the April ... president of The Feinstein Institute for Medical Research, says ... medical community,s approach to treating sepsis, which ... Americans. , Sepsis occurs when molecules released into the ... throughout the body. Inflammation is necessary for maintaining good ...
(Date:4/17/2014)... synthetic biology team has created a new technology ... that could travel the body and selectively target ... cell-based, biological devices that monitor and modify human ... biology. However, no existing technology enabled bioengineers to ... state and respond in a customized fashion. , ...
(Date:4/17/2014)... Doctors who treat patients with a severe and ... an agonizing treatment decision. , The drug sirolimus ... relieve shortness of breath. But some patients eventually ... potentially fatal complications following transplantation. , "It,s a ... director of Loyola University Medical Center,s LAM Clinic ...
(Date:4/17/2014)... NY (April 16, 2014) The cause of neuronal ... new study proposes that neurons may be mistaken for ... system, similar to the way autoimmune diseases like type ... body,s cells. The study was published April 16, 2014, ... new, and likely controversial, idea in Parkinson,s disease; but ...
(Date:4/17/2014)... By discovering a new mechanism that allows blood ... at UC Irvine and the Salk Institute have opened ... prevent stroke-induced brain damage. , A complex and devastating ... and primary reason for disability in the U.S. The ... lets blood-borne material into the brain, causing the permanent ...
Breaking Medicine News(10 mins):Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Building 'smart' cell-based therapies 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Is Parkinson's an autoimmune disease? 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2
... water to Sun City, Sun City West, and Town of Youngtown ... Arizona American Water will supply water to emergency services providers ... as part of an organized effort by the Salvation Army to ... in the Arizona desert easily exceed 110 degrees in the summer ...
... Co-Host of Innovative Medical Program , , BEVERLY HILLS, ... syndicated talk show The Doctors, is pleased to ... Daytime Emmy Award in the Outstanding Talk Show/Informative category. , ... of Television Arts & Sciences has selected us for such ...
... million are an hour or more away from quality treatment, ... of children in the United States live more than an ... trauma center, an amount of time that could prove deadly ... In the United States, more children aged 1-14 die of ...
... Advisories led to ,unintended consequences, researchers say , MONDAY, ... depression in America have dropped sharply since the government,s ... children and teens taking antidepressants, a new analysis finds. ... U.S. Food and Drug Administration,s advisories about the use ...
... stroke occurs, it often comes within a day, study shows, ... people who have a major stroke soon after a less ... "mini-stroke," do so within 24 hours of the minor event, ... who have a TIA is to "seek medical attention immediately, ...
... A new study released today of more than 20,000 men ... more than two decades of the number of adults with ... screening instruments to identify individuals entering jails with the most ... continuous treatment, a team of researchers from the nonpartisan Council ...
Cached Medicine News:Health News:Arizona American Water and Salvation Army Offer Aid on Hottest Days 2Health News:Respected Surgeon Receives Emmy Nomination 2Health News:1 in 3 U.S. Kids Lack Nearby Trauma Care 2Health News:Depression Treatment Wanes Following FDA Warnings 2Health News:Depression Treatment Wanes Following FDA Warnings 3Health News:Mini-Stroke Can Mean Major One Within Hours 2Health News:Mini-Stroke Can Mean Major One Within Hours 3Health News:New Study Documents High Prevalence of Serious Mental Illnesses Among Nation's Jail Populations 2
(Date:1/15/2014)... Ky. , Jan. 15, 2014  Manufacturers, suppliers ... must be able to protect their most important ... ) Because of ... it steadfastly remains one of the most litigious ...
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... its Symphony® CGM System as a non-invasive, wireless continuous ... Doman , Executive Chairman and Interim CEO of Echo ... Tenth Annual Equity Conference. Mr. Doman ...
(Date:1/15/2014)... 15, 2014 announces that a ... its catalogue: PharmaPoint: ... Market Analysis to 2022 ... - India Drug Forecast and Market Analysis ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
Stab incision blades color coded for simple and accurate identification...
Smooth, round edges allow for safe manipulation within the eye. 1.1mm wide gradually tapers to .50 mm wide. 45, 1.1mm wide, gradually tapers to .50mm wide....
... has two perforations which enable ... various single or bilateral configurations ... drape has two perforations which ... to various single or bilateral ...
30, 6.0mm from end...
Medicine Products: